Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.

Company Details

Registered Office: 704 Te Araroa Road RD3 Ruatoria 4083

Postal Address: 704 Te Araroa Road RD3 Ruatoria 4083

Telephone: +64-6-390-6938

Facsimile: n/a

Website: www.ruabio.com

First Listed: 22/10/2020

Balance Date: 30 June

AGM: 04/11/2024

Directors and Executives

Tony Barclay

Independent Director

Panapa Ehau

Executive Director

Teresa Farac-Ciprian Independent Non-Executive Director

Paul Naske

Chief Executive Officer

Anna Stove

Chair

Announcements

Title	Date	Type
Quotation Notice - Rua Bioscience Limited (“RUARB”) Rights	Mon, Nov 03 2025 09:25 am	OFFER
Rua announces details of capital raise	Mon, Nov 03 2025 08:39 am	OFFER
Results of 2025 Annual Shareholders' Meeting	Wed, Oct 29 2025 08:59 am	MEETING
Rua Bioscience ASM Presentation and Commentary	Tue, Oct 28 2025 02:13 pm	MEETING
Amendment: Ongoing Disclosure Notice - Teresa Farac-Ciprian	Thu, Oct 23 2025 11:54 am	SHINTR
Record sales month in New Zealand and Australia	Wed, Oct 08 2025 08:30 am	MKTUPDTE
Rua Releases Annual Report for Year Ended 30 June 2025	Mon, Sep 29 2025 05:09 pm	ANNREP
Rua Bioscience Notice of Annual Shareholder Meeting	Mon, Sep 29 2025 03:06 pm	MEETING
Capital Change Notice - Employee allocation	Fri, Sep 19 2025 02:03 pm	SECISSUE
Capital Change Notice	Fri, Sep 12 2025 10:19 am	SECISSUE

Major Holdings Announcements

Date	Name	No. Held	%	Current
10/10/23	Hikurangi Enterprises Limited	10,532,620	5.43	6.66
22/12/22	Michael John Wilding	8,509,556	-	5.39
17/03/22	Hikurangi Bioactives Limited Partne	4,000,000	12.58	2.67
22/10/20	Tailorspace Capital Limited, Tailor	11,129,375	-	7.95
22/10/20	Fang Group Investment Limited and F	23,584,939	-	16.85
22/10/20	Andrew Charles Williams	7,756,838	-	5.54

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
20/08/25	Antony George Barclay	2,139,376	-	-	-
13/12/24	Teresa Farac-Ciprian	525,000	-	-	-
13/12/24	Paul Naske	189,872	-	-	-
31/05/23	Hamish White	80,895	-	-	-
02/11/21	Trevor Burt	958,002	-	-	-
02/11/21	Panapa Ehau	474,224	-	-	-
02/11/21	Rob Mitchell	288,251	-	-	-
22/10/20	Martin Smith	2,544,732	-	-	-
22/10/20	Brett Gamble	1,805,914	-	-	-
22/10/20	Anna Stove	763,896	-	-	-

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 04/09/2025